✨ Free AI Report
Ventas, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Ventas, Inc.
Company Research

Ventas, Inc.: Business Overview, Financials & Competitive Analysis

Ventas, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Healthcare REIT with compelling demographic tailwinds and strong execution driving consistent FFO growth. In 2025, Ventas's revenue was $5.82 billion, an increase of 18.99% compared to the previous year's $4.89 billion. According to 13 analysts, the average rating for VTR stock is 'Buy.' Strong demographic tailwinds from an aging population.

What is Ventas, Inc.'s industry? Ventas, Inc. (ventasreit.com) operates in Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office. AskCyborg classifies Ventas, Inc. under Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office in its company registry.

Ventas, Inc. is a leading S&P 500 real estate investment trust with approximately 1,400 properties in North America and the United Kingdom that occupies an essential role in the longevity economy. The company's growth...

8/ 10Strong

Cyborg Score thesis

Healthcare REIT with compelling demographic tailwinds and strong execution driving consistent FFO...

Read the full analyst-debate transcript →
Industry Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Ventas, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Ventas, Inc.

AskCyborg analysts argue the bull and bear cases for Ventas, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Ventas, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Ventas, Inc. Overview

Pro stress-test →

Ventas, Inc. is a leading S&P 500 real estate investment trust with approximately 1,400 properties in North America and the United Kingdom that occupies an essential role in the longevity economy. The company's growth is fueled by its more than 850 senior housing communities.

Strategic Profile

Pro stress-test →

Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities.

Competitive Landscape

Pro stress-test →

Ventas competes with other healthcare-focused REITs in the senior housing and medical office sectors. Key competitors include Welltower, Healthpeak Properties, Omega Healthcare Investors, CareTrust REIT, and National Health Investors. Ventas differentiates itself through its large diversified portfolio, operational expertise via Ventas OI data platform, and strong balance sheet.

Industry Context

Ventas, Inc. operates in Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office.

Key facts

Founded: 1983 · Headquarters: Chicago, US · Employees: 1,000+ · Revenue: $5.82B · Market cap: $29B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Ventas, Inc..

  • Revenue grew 19% YoY to $5.82B in 2025 with earnings up 210%
  • Senior Housing Operating Portfolio (SHOP) delivered double-digit NOI growth with accelerating occupancy
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025Announced quarterly dividend of $0.48 per share
  • January 2026Announced Peter Bulgarelli retirement effective May 1, 2026
  • +1 moreTrack every material event for Ventas, Inc. as it happens. Explore monitoring →
Get alerted when Ventas, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

WelltowerDiversified healthcare REIT with senior housing and medical offices→Healthpeak PropertiesHealthcare REIT focused on life science and medical office→Omega Healthcare InvestorsSkilled nursing facility and senior housing REIT→National Health InvestorsSenior housing and medical office REIT→

Compare Ventas, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Ventas, Inc. operates in Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office research →
NEW · MCP server

Ask your AI assistant about Ventas, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Ventas, Inc. and its top competitor on Cyborg Score”
“What did Ventas, Inc. do this quarter?”
“Is Ventas, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Ventas, Inc. do?+
Ventas, Inc. is a leading S&P 500 real estate investment trust with approximately 1,400 properties in North America and the United Kingdom that occupies an essential role in the longevity economy. The company's growth...
What is Ventas, Inc.'s Cyborg Score?+
Ventas, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Ventas, Inc.'s main competitors?+
Named competitors include Welltower, Healthpeak Properties, Omega Healthcare Investors, National Health Investors. The full competitive landscape is in the AskCyborg report.
How can I get the full Ventas, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Ventas, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Ventas, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Welltower Inc.